Literature DB >> 14651966

Plasminogen-induced IL-1beta and TNF-alpha production in microglia is regulated by reactive oxygen species.

Kyoung-jin Min1, Ilo Jou, Eunhye Joe.   

Abstract

Microglia, major immune effector cells in the central nervous system, become activated during brain injury. In this study we showed that the blood component plasminogen/plasmin activates microglia. Plasminogen-induced IL-1beta, TNF-alpha, and iNOS mRNA expression in primary cultured rat microglia and BV2 murine microglial cells. Plasmin caused a similar response. Serine protease inhibitors suppressed both plasminogen- and plasmin-induced IL-1beta and TNF-alpha expression, indicating the importance of serine protease activity in plasminogen/plasmin activation of microglia. Reactive oxygen species (ROS) appeared to play an important role in plasminogen-induced microglial activation, with ROS being generated within 15min of plasminogen treatment, and antioxidants (100 microM trolox and 10mM NAC) reducing IL-1beta and TNF-alpha expression in plasminogen-treated cells. Furthermore, plasminogen stimulated CREB and NF-kappaB DNA binding activity, and this activation was also reduced by trolox and NAC. These results suggest that plasminogen activates microglia via stimulation of ROS production.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14651966     DOI: 10.1016/j.bbrc.2003.11.010

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  23 in total

1.  Fluoxetine prevents oligodendrocyte cell death by inhibiting microglia activation after spinal cord injury.

Authors:  Jee Y Lee; So R Kang; Tae Y Yune
Journal:  J Neurotrauma       Date:  2015-03-06       Impact factor: 5.269

2.  Microglia play a role in ethanol-induced oxidative stress and apoptosis in developing hypothalamic neurons.

Authors:  Nadka I Boyadjieva; Dipak K Sarkar
Journal:  Alcohol Clin Exp Res       Date:  2012-07-23       Impact factor: 3.455

3.  Hyperhomocysteinemia regulated SCF expression in cultured cardiomyocytes via modulation of NF-κB activities.

Authors:  Xia Zhao; Dong Kuang; Yuping Duan; Guixiang Xiao; Juan Ni; Yaqi Duan; Guoping Wang
Journal:  Mol Cell Biochem       Date:  2015-04-21       Impact factor: 3.396

4.  Astrocyte activation and wound healing in intact-skull mouse after focal brain injury.

Authors:  Takayuki Suzuki; Honami Sakata; Chiaki Kato; John A Connor; Mitsuhiro Morita
Journal:  Eur J Neurosci       Date:  2012-09-27       Impact factor: 3.386

5.  Poly(amidoamine) dendrimer-drug conjugates with disulfide linkages for intracellular drug delivery.

Authors:  Yunus E Kurtoglu; Raghavendra S Navath; Bing Wang; Sujatha Kannan; Robert Romero; Rangaramanujam M Kannan
Journal:  Biomaterials       Date:  2009-01-25       Impact factor: 12.479

6.  Neural inflammation and the microglial response in diabetic retinopathy.

Authors:  Steven F Abcouwer
Journal:  J Ocul Biol Dis Infor       Date:  2012-04-24

7.  In vitro testing for anti-inflammatory properties of compounds employing peripheral blood mononuclear cells freshly isolated from healthy donors.

Authors:  M Jenny; M Klieber; D Zaknun; S Schroecksnadel; K Kurz; M Ledochowski; H Schennach; Dietmar Fuchs
Journal:  Inflamm Res       Date:  2010-08-26       Impact factor: 4.575

Review 8.  Plasmin-dependent modulation of the blood-brain barrier: a major consideration during tPA-induced thrombolysis?

Authors:  Be'eri Niego; Robert L Medcalf
Journal:  J Cereb Blood Flow Metab       Date:  2014-06-04       Impact factor: 6.200

Review 9.  Opioid administration following spinal cord injury: implications for pain and locomotor recovery.

Authors:  Sarah A Woller; Michelle A Hook
Journal:  Exp Neurol       Date:  2013-03-15       Impact factor: 5.330

10.  Astrocytes induce hemeoxygenase-1 expression in microglia: a feasible mechanism for preventing excessive brain inflammation.

Authors:  Kyoung-Jin Min; Myung-soon Yang; Seung-Up Kim; Ilo Jou; Eun-hye Joe
Journal:  J Neurosci       Date:  2006-02-08       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.